ArticleMolecular therapy. Methods & clinical development2014

Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor.

Orit Wolstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.